U.S. RESEARCH ROUNDUP-Axsome Therapeutics, Ducommun, Vacasa
Dec 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Axsome Therapeutics, Ducommun and Vacasa on Tuesday.
HIGHLIGHTS
* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $133 from $130 |
* Comstock Resources Inc CRK.N: Gerdes Energy Research cuts to sell from neutral |
* Ducommun Inc DCO.N: RBC reinstates coverage with outperform rating |
* Glaukos Corp GKOS.N: Stifel raises target price to $175 from $153 |
* Vacasa Inc VCSA.O: Needham cuts to hold from buy |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Axsome Therapeutics Inc AXSM.O: Mizuho cuts target price to $122 from $124 |
* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $133 from $130 |
* Axsome Therapeutics Inc AXSM.O: RBC raises target price to $138 from $132 |
* Cal-Maine Foods Inc CALM.O: Stephens raises target price to $88 from $82 |
* Canoo Inc GOEV.O: Stifel cuts target price to $0.50 from $4.50 |
* Canoo Inc GOEV.O: Stifel cuts to hold from buy |
* Comstock Resources Inc CRK.N: Gerdes Energy Research cuts to sell from neutral |
* Ducommun Inc DCO.N: RBC reinstates coverage with outperform rating |
* Ducommun Inc DCO.N: RBC reinstates coverage with price target $72 vs $60 |
* FTAI Aviation Ltd FTAI.O: BTIG raises target price to $190 from $180 |
* Glaukos Corp GKOS.N: Stifel raises target price to $175 from $153 |
* Marinus Pharmaceuticals Inc MRNS.O: Baird raises target price to $0.55 from $0.50 |
* Merit Medical Systems Inc MMSI.O: Raymond James raises target price to $110 from $105 |
* Vacasa Inc VCSA.O: Needham cuts to hold from buy |
* Verastem Inc VSTM.O: BTIG raises target price to $20 from $13 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Related Articles
Can Palantir Stock Be a Big Winner For Investors Again in 2025?
TradingKey - Any investor who had a stake in large cap Artificial Intelligence (AI) stocks in 2024 probably did pretty well. That was down to the fact that the thematic powered the US stock market higher last year, with the S&P 500 Index ending the year up 23.3%.
1 Stock To Buy for the Renewable Energy Revolution
TradingKey - When we talk about renewable energy and the boom in demand for cleaner sources of fuel, many investors may think the biggest winners are companies involved in electric vehicles (EVs) or solar panel production.
What to Expect at CES 2025
TradingKey - As a barometer for the tech economy, CES 2025 is set to kick off on January 5 in Las Vegas, reaffirming its position as one of the world's largest tech exhibitions.
